BioLine RX Ltd (NASDAQ:BLRX)

0.8578
Delayed Data
As of Apr 20
 -0.0021 / -0.24%
Today’s Change
0.80
Today|||52-Week Range
1.34
-21.30%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for BioLine RX Ltd have a median target of 3.00, with a high estimate of 4.00 and a low estimate of 2.00. The median estimate represents a +249.73% increase from the last price of 0.86.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in BioLine RX Ltd. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.07
Sales
$0.00
Reporting Date
May 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -0.21%
 
 
 
 
 
 
Growthannually -5.77%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.